➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
Harvard Business School

Last Updated: July 29, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Daprodustat

Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Daprodustat?

Daprodustat is an investigational drug.

There have been 13 clinical trials for Daprodustat. The most recent clinical trial was a Phase 1 trial, which was initiated on May 11th 2017.

The most common disease conditions in clinical trials are Renal Insufficiency, Chronic, Anemia, and Kidney Diseases. The leading clinical trial sponsors are GlaxoSmithKline, Quintiles, Q2 Solutions, HemoCue, ERT, and [disabled in preview].

There are nine US patents protecting this investigational drug and ninety-eight international patents.

Recent Clinical Trials for Daprodustat
Comparison of Daprodustat Formulations Produced by Two Methods of Manufacture for Bioequivalence and Dissolution in Healthy ParticipantsGlaxoSmithKlinePhase 1
Oral Iron Absorption StudyGlaxoSmithKlinePhase 2
Forearm Blood Flow in Chronic Kidney Disease Subjects With Anemia (FBF-CKD)GlaxoSmithKlinePhase 2

See all Daprodustat clinical trials

Clinical Trial Summary for Daprodustat

Top disease conditions for Daprodustat
Top clinical trial sponsors for Daprodustat

See all Daprodustat clinical trials

US Patents for Daprodustat

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Daprodustat ⤷  Try it Free Controlled release dosage form TRIASTEK, INC. (Nanjing, CN) ⤷  Try it Free
Daprodustat ⤷  Try it Free Bicyclic-fused heteroaryl or aryl compounds as IRAK4 modulators Pfizer Inc. (New York, NY) ⤷  Try it Free
Daprodustat ⤷  Try it Free Oral drug dosage forms having desired drug release profiles and uses thereof Triastek, Inc. (Nanjing, CN) ⤷  Try it Free
Daprodustat ⤷  Try it Free Heterocyclic compounds as inhibitors of Vanin-1 enzyme Pfizer Inc. (New York, NY) ⤷  Try it Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Daprodustat

Drugname Country Document Number Estimated Expiration Related US Patent
Daprodustat Australia AU2017261372 2036-05-05 ⤷  Try it Free
Daprodustat Canada CA3023278 2036-05-05 ⤷  Try it Free
Daprodustat China CN107847398 2036-05-05 ⤷  Try it Free
Daprodustat European Patent Office EP3452003 2036-05-05 ⤷  Try it Free
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.